2015-2019 US Coagulation Testing Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies

June 2015 | 424 pages | ID: 2C832DDB081EN
Venture Planning Group

Abstracts

Complete report $9,600. DataPack (test volumes, sales forecasts, supplier shares) $6,200. SummaryThis comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the next five years. The report explores business and technological trends in the US coagulation testing market; provides estimates of the test volume, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years. Coagulation TestsActivated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2 Antiplasmin, Antithrombin III, Bleeding Time, D Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX, Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre Kallikrein Factor Activation, Heparin/Anti Factor Xa, Heparin Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrand's Factor Fav/Ag, and othersSales and Market Share AnalysisSales and market shares of major instrument and reagent suppliers. Competitive AssessmentsExtensive strategic profiles of major suppliers and emerging market entrants. Market Segmentation Analysis Comprehensive market segmentation analysis, including: Hospitals Commercial/Private Laboratories Physician Offices Test volume forecasts for over 40 major procedures by market segment. Current and Emerging Products Review of established and emerging procedures. Comparison of automated and semi automated analyzers from Diagnostica Stago, Helena, IL, Siemens, Sysmex and other suppliers.

Technology Review Analysis of current and emerging technologies and their potential market applications. Comprehensive lists of companies developing or marketing new technologies and products by test.

Strategic Recommendations

Product development and business expansion opportunities with significant market appeal. Ideal product models with tentative prices and operating characteristics. Alternative market penetration strategies for instrument and reagent suppliers. Potential market entry barriers and risks.

Contains 424 pages and 37 tables

Contents

1. INTRODUCTION

2. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Major Routine and Special Coagulation Tests
  1. Introduction
  2. Activated Partial Thromboplastin Time (APTT)
  3. Alpha-2 Antiplasmin
  4. Antithrombin III
  5. Bleeding Time
  6. DDimer
  7. Ethanol Flocculation Test
  8. Euglobulin Lysis
  8. Factor Assays
    a. Introduction
    b. Factor II
    c. Factor V/Factor V Leiden
    d. Factor VII
    e. Factor VIII
    f. Factor IX
    g. Factor IXa
    h. Factor X (Stuart Factor)
    i. Factor Xa
    j. Factor XI
    k. Factor XII
    l. Factor XIII
  10. Fibrin Degradation Products
  11. Fibrinogen
  12. Heparin
  13. Hirudin
  14. Hypercoagulability and Thrombosis
  15. Lipoprotein a
  16. Plasmin
  17. Plasminogen
  18. Plasminogen Activator Inhibitor (PAI)
  19. Platelet Function Tests
  20. Platelet Aggregation
  21. Proteins C and S
  22. Prothrombin Fragment  1.2
  23. Prothrombin Time (PT)
  24. Reptilase Time
  25. Thrombin Time
  26. Tissue Type Plasminogen Activator (t PA)
  27. Von Willebrand's Factor
B. Instrumentation Review
C. Major in Vitro Diagnostic Technologies and Their Potential Applications
  1. Chromogenic Substrates
  2. Monoclonal and Polyclonal Antibodies
  3. Immunoassays
  4. Molecular Diagnostics
  5. Microcomputers
  6. Automation
  7. Robotics
  8. Artificial Intelligence
  8. Dry Chemistry
  10. Biosensors

3. U.S.A.

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Instrument and Reagent SuppliersҠSales and Market Shares

10. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

11. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

12. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types Of Distributors
  7. Market Segmentation

13. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

14. COMPETITIVE ASSESSMENTS

    Abbott
    ADI/American Diagnostic
    Alere/Biosite/Inverness
    Axis    Shield
    Beckman Coulter/Danaher
    Becton Dickinson
    Bio/Data Corporation
    Chrono Log
    Corgenix Medical
    Diagnostica Stago/Trinity Biotech
    Helena Laboratories
    HYPEN BioMed
    Instrumentation Laboratory
    ITC

    Roche
    Siemens
    Sienco
    Sysmex
    Thermo Fischer
    ZyCare/Alere

List Of Tables

LIST OF TABLES

Major Companies Developing or Marketing Activated Clotting Time Tests
Major Companies Developing or Marketing APTT Tests
Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
Major Companies Developing or Marketing Antithrombin III Tests
Major Companies Developing or Marketing Bleeding Time Tests
Major Companies Developing or Marketing Ddimer Tests
Major Companies Developing or Marketing Factor Assays
Major Companies Developing or Marketing Fibrin Degradation Product Tests
Major Companies Developing or Marketing Fibrinogen Tests
Major Companies Developing or Marketing Heparin Tests
Major Companies Developing or Marketing Plasmin Tests
Major Companies Developing or Marketing Plasminogen Tests
Major Companies Developing or Marketing Plasminogen Activator Inhibitor Tests
Major Companies Developing or Marketing Platelet Aggregation Tests
Major Companies Developing or Marketing Protein C Tests
Major Companies Developing or Marketing Protein S Tests
Major Companies Developing or Marketing PT Tests
Major Companies Developing or Marketing Thrombin Time Tests
Major Companies Developing or Marketing TPA Tests
Major Companies Developing or Marketing Von Willebrand's Factor Tests
Executive Summary Table: U.S.A., Total Coagulation Diagnostics Market By Market Segment and Product Category
U.S.A., Laboratories Performing Coagulation Tests By Market Segment
U.S.A., Hospital Laboratories Performing Coagulation Tests By Bed Size
U.S.A., Commercial/Private Laboratories Performing Coagulation Tests By Annual Test Volume
U.S.A., Hospital Laboratories Average Daily Test Volume
U.S.A., Commercial/Private Laboratories Average Daily Test Volume
U.S.A., Physician Offices/Group Practices Average Daily Test Volume
U.S.A., Total Coagulation Test Volume By Market Segment
U.S.A., All Market Segments Coagulation Test Volume
U.S.A., Hospital Laboratories Coagulation Test Volume
U.S.A., Commercial/Private Laboratories Coagulation Test Volume
U.S.A., Physician Offices/Group Practices Coagulation Test Volume
U.S.A., Coagulation Reagent Market By Market Segment
U.S.A., Major Suppliers of Coagulation Reagents Estimated Sales and Market Shares
U.S.A., Coagulation Instrument Market By Market Segment
U.S.A., Major Suppliers of Coagulation Analyzers, Estimated Instrument Sales and Market Shares
U.S.A., Total Coagulation Diagnostics Market By Product Category
U.S.A., Major Suppliers of Coagulation Diagnostic Products, Estimated Sales and Market Shares